Elekta gets FDA OK for Fraxion head frame
Article Thumbnail ImageFebruary 17, 2012 -- Oncology firm Elekta has received clearance from the U.S. Food and Drug Administration for its Fraxion head frame.

To view the remainder of this article, and other exclusive content, you must first sign-in or register using the options below.
(Helptag:PaywallArticleLoginMessage)
Member Sign In:
  MemberID or E-mail Address:
  Password:
(?)

New AuntMinnie.com Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • OnLine CMe/CE
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
  • Fraxion is designed to immobilize the cranium, thus helping to ensure accuracy in stereotactic radiation therapy of cancer targets in the brain and cranium, Elekta said.

    The patient can be immobilized with a thermoplastic mask, with the vacuum mouthpiece, or a combination of both systems. The partial and full head thermoplastic masks provide alternative immobilization options for noninvasive setup.


    || About || Advertising || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2013 || Education || Equipment Classifieds || Facebook || Forums || Home || Links || Marketplace || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2012 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2013 AuntMinnie.com. All Rights Reserved.